NCT03255850 is a clinical trial in Congenital Heart Disease, sponsored by The University of Hong Kong.

Who is sponsoring NCT03255850?

NCT03255850 is sponsored by The University of Hong Kong.

What condition does NCT03255850 study?

NCT03255850 studies Congenital Heart Disease.

Is NCT03255850 still recruiting?

NCT03255850 is currently completed. Last updated 21 September 2018.

Last reviewed 2018-09-21 · How we verify

NCT03255850

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Impact of Congenital Heart Disease on the Psychological Well Being and Quality of Life in the Hong Kong Chinese Adolescents

Completed Last updated 21 September 2018

What this trial tests

trial in Congenital Heart Disease in 96 participants. Completed in 31 August 2018.

Timeline

15 August 2017

Primary endpoint
31 August 2018

31 August 2018

Quick facts

Lead sponsor	The University of Hong Kong
Status	Completed
Study type	OBSERVATIONAL
Enrollment	96
Start date	15 August 2017
Primary completion	31 August 2018
Estimated completion	31 August 2018
Sites	1 location across Hong Kong

Conditions studied

Congenital Heart Disease — all drugs for Congenital Heart Disease →

Sponsor

The University of Hong Kong

Who can join

Adults 12 to 17, any sex, with Congenital Heart Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to examine the psychological well-being and QoL of Hong Kong Chinese adolescents with CHD by * comparing the self-esteem level, depressive symptoms, and quality of life of adolescents suffering from CHD with healthy norms and cancer survivors. * identifying possible factors affecting the quality of life of adolescents suffering from CHD.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The impact of congenital heart disease on the psychological well-being and quality of life of Hong Kong Chinese adolescents: A cross-sectional study.
So SCY, Li WHC, Ho KY. · · 2019 · cited 16× · PMID 30938874 · DOI 10.1111/jocn.14864

Verify or expand the search:

Other recruiting trials for Congenital Heart Disease

Currently open trials in the same condition.

NCT07193719 — Influence of Personalized Lung Volume Optimization Maneuver on Lung Function and Cardiac Performance in Children · Phase 1, PHASE2 · recruiting
NCT07023367 — Parent Navigator Program (PNP) to Improve Outcomes in Latino/x Children and Parents · NA · recruiting
NCT06833320 — Propranolol Treatment for Postoperative Chylothorax · Phase 1, PHASE2 · recruiting
NCT06668389 — Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary · Phase 4 · recruiting
NCT06872320 — The Influence of Probiotics on Metabolome and Heart Rate Variability in Heart Failure of Structure Heart Disease · NA · active not recruiting

Other The University of Hong Kong trials

Trials by the same sponsor.

NCT05981430 — Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae · NA · not yet recruiting
NCT07478757 — Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized · NA · not yet recruiting
NCT07448649 — Chatbot-Assisted Advance Care Planning Education for Family Members · NA · not yet recruiting
NCT07484932 — TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer · NA · not yet recruiting
NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03255850 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Hong Kong
Last refreshed: 21 September 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03255850.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing